中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Emodin, a natural product, selectively inhibits 11 beta-hydroxysteroid dehydrogenase type 1 and ameliorates metabolic disorder in diet-induced obese mice

文献类型:期刊论文

作者Feng, Ying; Huang, Su-Ling; Dou, Wei; Zhang, Song; Chen, Jun-Hua; Shen, Yu; Shen, Jian-Hua; Leng, Ying
刊名BRITISH JOURNAL OF PHARMACOLOGY
出版日期2010-09
卷号161期号:1页码:113-126
关键词emodin 11 beta-hydroxysteroid dehydrogenase type 1 diet-induced obese mice insulin resistance metabolic syndrome type 2 diabetes
ISSN号0007-1188
DOI10.1111/j.1476-5381.2010.00826.x
文献子类Article
英文摘要BACKGROUND AND PURPOSE 11 beta-Hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) is an attractive therapeutic target of type 2 diabetes and metabolic syndrome. Emodin, a natural product and active ingredient of various Chinese herbs, has been demonstrated to possess multiple biological activities. Here, we investigated the effects of emodin on 11 beta-HSD1 and its ability to ameliorate metabolic disorders in diet-induced obese (DIO) mice. EXPERIMENTAL APPROACH Scintillation proximity assay was performed to evaluate inhibition of emodin against recombinant human and mouse 11 beta-HSDs. The ability of emodin to inhibit prednisone- or dexamethasone-induced insulin resistance was investigated in C57BL/6J mice and its effect on metabolic abnormalities was observed in DIO mice. KEY RESULTS Emodin is a potent and selective 11 beta-HSD1 inhibitor with the IC50 of 186 and 86 nM for human and mouse 11 beta-HSD1, respectively. Single oral administration of emodin inhibited 11 beta-HSD1 activity of liver and fat significantly in mice. Emodin reversed prednisone-induced insulin resistance in mice, whereas it did not affect dexamethasone-induced insulin resistance, which confirmed its inhibitory effect on 11 beta-HSD1 in vivo. In DIO mice, oral administration of emodin improved insulin sensitivity and lipid metabolism, and lowered blood glucose and hepatic PEPCK, and glucose-6-phosphatase mRNA. CONCLUSIONS AND IMPLICATIONS This study demonstrated a new role for emodin as a potent and selective inhibitor of 11 beta-HSD1 and its beneficial effects on metabolic disorders in DIO mice. This highlights the potential value of analogues of emodin as a new class of compounds for the treatment of metabolic syndrome or type 2 diabetes.
WOS关键词HEPATIC INSULIN SENSITIVITY ; HUMAN ADIPOSE-TISSUE ; IN-VIVO ; GLUCOSE-TOLERANCE ; VISCERAL OBESITY ; CARBENOXOLONE ; GLUCOCORTICOIDS ; DEXAMETHASONE ; RESISTANCE ; GENE
资助项目National Basic Research Program of China[2009CB522300] ; National Nature Science Foundation of China[30873106] ; Shanghai Rising-Star Foundation[08QH14028] ; National Science & Technology Major Project 'Key New Drug Creation and Manufacturing Program', China[2009ZX09103-061] ; Science and Technology Commission of Shanghai Municipality[08DZ1980200]
WOS研究方向Pharmacology & Pharmacy
语种英语
WOS记录号WOS:000281061900009
出版者WILEY-BLACKWELL
源URL[http://119.78.100.183/handle/2S10ELR8/278784]  
专题药理学第一研究室
中科院受体结构与功能重点实验室
新药研究国家重点实验室
通讯作者Leng, Ying
作者单位Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China
推荐引用方式
GB/T 7714
Feng, Ying,Huang, Su-Ling,Dou, Wei,et al. Emodin, a natural product, selectively inhibits 11 beta-hydroxysteroid dehydrogenase type 1 and ameliorates metabolic disorder in diet-induced obese mice[J]. BRITISH JOURNAL OF PHARMACOLOGY,2010,161(1):113-126.
APA Feng, Ying.,Huang, Su-Ling.,Dou, Wei.,Zhang, Song.,Chen, Jun-Hua.,...&Leng, Ying.(2010).Emodin, a natural product, selectively inhibits 11 beta-hydroxysteroid dehydrogenase type 1 and ameliorates metabolic disorder in diet-induced obese mice.BRITISH JOURNAL OF PHARMACOLOGY,161(1),113-126.
MLA Feng, Ying,et al."Emodin, a natural product, selectively inhibits 11 beta-hydroxysteroid dehydrogenase type 1 and ameliorates metabolic disorder in diet-induced obese mice".BRITISH JOURNAL OF PHARMACOLOGY 161.1(2010):113-126.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。